Welcome to the official website of BioCoreUSA Corp!
  • Cores:
    150
    CASES:
    75
    Core Diameter(mm):
    1
    Thickness(µm):
    5
    Row number:
    10
    Column number:
    15
    Tissue Array Type:
    FFPE
    Species:
    Human
FUR1501
$215.00
Add To Collect

Description: Uterus cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores

Details: Endometrioid adenocarcinoma tissue microarray, containing 58 cases of endometrioid adenocarcinoma, 2 each of chorionic carcinoma and squamous cell carcinoma, 4 adenosquamous carcinoma, 1 clear cell carcinoma, 3 stromal sarcoma, 2 atypical hyperplasia, plus 3 normal endometrium tissue, duplicate cores per case (duplicated cores from the same patient were put onto upper and lower rows in the same position)

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • Hyperplasia(*)
  • Normal(*)
  • Malignant(I)
  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IC)
  • Malignant(IIA)
  • Malignant(IIB)
  • Malignant(II)
  • Malignant(IIIC)
  • Malignant(III)
  • _ph
TISSUE ARRAYS
FUR1501
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
A
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
B
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
C
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
D
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
E
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
F
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
G
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
H
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
I
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
J
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
_ph
FUR1501
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type
A1
1 60 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
A2
2 58 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
A3
3 44 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
A4
4 76 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant
A5
5 60 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant
A6
6 48 F Uterus Adenocarcinoma (sparse) 2 T1bN0M0 IB Malignant
A7
7 51 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
A8
8 42 F Uterus Adenocarcinoma (sparse) * T1aN0M0 IA Malignant
A9
9 58 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant
A10
10 65 F Uterus Endometrioid adenocarcinoma (sparse) 2 T1cN0M0 IC Malignant
A11
11 36 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
A12
12 60 F Uterus Endometrioid adenocarcinoma with necrosis 1 T2bN0M0 IIB Malignant
A13
13 40 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
A14
14 45 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant
A15
15 73 F Uterus Endometrioid adenocarcinoma 1 T1cN0M0 IC Malignant
B1
16 60 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
B2
17 58 F Uterus Endometrioid adenocarcinoma (smooth muscle and blood vessel) * T1bN0M0 IB Malignant
B3
18 44 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
B4
19 76 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant
B5
20 60 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant
B6
21 48 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
B7
22 51 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
B8
23 42 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant
B9
24 58 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant
B10
25 65 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
B11
26 36 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
B12
27 60 F Uterus Endometrioid adenocarcinoma with necrosis 1 T2bN0M0 IIB Malignant
B13
28 40 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
B14
29 45 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant
B15
30 73 F Uterus Endometrioid adenocarcinoma 1 T1cN0M0 IC Malignant
C1
31 57 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
C2
32 65 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
C3
33 55 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant
C4
34 55 F Uterus Endometrioid adenocarcinoma 2 T2aN0M0 IIA Malignant
C5
35 64 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
C6
36 60 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
C7
37 72 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
C8
38 50 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
C9
39 57 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
C10
40 49 F Uterus Endometrioid adenocarcinoma (sparse) 2 T1bN0M0 IB Malignant
C11
41 58 F Uterus Endometrioid adenocarcinoma 2--3 T1bN0M0 IB Malignant
C12
42 62 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
C13
43 74 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
C14
44 57 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
C15
45 50 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
D1
46 57 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
D2
47 65 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
D3
48 55 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant
D4
49 55 F Uterus Endometrioid adenocarcinoma 2 T2aN0M0 IIA Malignant
D5
50 64 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
D6
51 60 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
D7
52 72 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
D8
53 50 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
D9
54 57 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
D10
55 49 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
D11
56 58 F Uterus Endometrioid adenocarcinoma 2--3 T1bN0M0 IB Malignant
D12
57 62 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
D13
58 74 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
D14
59 57 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
D15
60 50 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
E1
61 51 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
E2
62 66 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
E3
63 51 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
E4
64 58 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
E5
65 55 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
E6
66 56 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
E7
67 54 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
E8
68 62 F Uterus Endometrioid adenocarcinoma 2 T1cN1M0 IIIC Malignant
E9
69 67 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
E10
70 70 F Uterus Endometrioid adenocarcinoma (sparse) 2 T1bN0M0 IB Malignant
E11
71 54 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
E12
72 56 F Uterus Endometrioid adenocarcinoma 3 T1aN0M0 IA Malignant
E13
73 46 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
E14
74 52 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
E15
75 51 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
F1
76 51 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
F2
77 66 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
F3
78 51 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
F4
79 58 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
F5
80 55 F Uterus Endometrioid adenocarcinoma (sparse) 2 T1cN0M0 IC Malignant
F6
81 56 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
F7
82 54 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
F8
83 62 F Uterus Endometrioid adenocarcinoma 2 T1cN1M0 IIIC Malignant
F9
84 67 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
F10
85 70 F Uterus Endometrioid adenocarcinoma (smooth muscle and blood vessel) * T1bN0M0 IB Malignant
F11
86 54 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
F12
87 56 F Uterus Endometrioid adenocarcinoma 3 T1aN0M0 IA Malignant
F13
88 46 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
F14
89 52 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
F15
90 51 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
G1
91 52 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
G2
92 63 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
G3
93 53 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
G4
94 48 F Uterus Endometrioid adenocarcinoma 3 T3N0M0 III Malignant
G5
95 56 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
G6
96 48 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant
G7
97 58 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
G8
98 46 F Uterus Endometrioid adenocarcinoma 3 T2bN0M0 IIB Malignant
G9
99 58 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
G10
100 61 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
G11
101 44 F Uterus Endometrioid adenocarcinoma (tumoral necrosis) * T1bN0M0 IB Malignant
G12
102 55 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
G13
103 54 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
G14
104 57 F Uterus Chorionic carcinoma * T1cN0M0 IC Malignant
G15
105 42 F Uterus Chorionic carcinoma * T1cN0M0 IC Malignant
H1
106 52 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant
H2
107 63 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
H3
108 53 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
H4
109 48 F Uterus Endometrioid adenocarcinoma 3 T3N0M0 III Malignant
H5
110 56 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
H6
111 48 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant
H7
112 58 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
H8
113 46 F Uterus Endometrioid adenocarcinoma 3 T2bN0M0 IIB Malignant
H9
114 58 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
H10
115 61 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
H11
116 44 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
H12
117 55 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
H13
118 54 F Uterus Endometrioid adenocarcinoma 3 T1cN0M0 IC Malignant
H14
119 57 F Uterus Chorionic carcinoma * T1cN0M0 IC Malignant
H15
120 42 F Uterus Chorionic carcinoma * T1cN0M0 IC Malignant
I1
121 54 F Uterus Adenosquamous carcinoma * T2bN0M0 IIB Malignant
I2
122 60 F Uterus Adenosquamous carcinoma * T2aN0M0 IIA Malignant
I3
123 67 F Uterus Adenosquamous carcinoma * T2aN0M0 IIA Malignant
I4
124 49 F Uterus Adenosquamous carcinoma * T1cN0M0 IC Malignant
I5
125 70 F Uterus Clear cell carcinoma * T1bN0M0 IB Malignant
I6
126 26 F Uterus Stromal sarcoma * T2N0M0G1 IB Malignant
I7
127 26 F Uterus Stromal sarcoma * T2N0M0G1 IB Malignant
I8
128 44 F Uterus Stromal sarcoma * T2N0M0G1 IB Malignant
I9
129 53 F Uterus Squamous cell carcinoma 3 T1cN0M0 IC Malignant
I10
130 55 F Uterus Squamous cell carcinoma 3 T1cN0M0 IC Malignant
I11
131 47 F Uterus Atypical hyperplasia 2--3 * * Hyperplasia
I12
132 48 F Uterus Mild hyperplasia * * * Hyperplasia
I13
133 21 F Uterus Endometrium tissue * * * Normal
I14
134 21 F Uterus Endometrium tissue * * * Normal
I15
135 18 F Uterus Endometrium tissue * * * Normal
J1
136 54 F Uterus Adenosquamous carcinoma * T2bN0M0 IIB Malignant
J2
137 60 F Uterus Adenosquamous carcinoma (sparse) * T2aN0M0 IIA Malignant
J3
138 67 F Uterus Adenosquamous carcinoma * T2aN0M0 IIA Malignant
J4
139 49 F Uterus Adenosquamous carcinoma * T1cN0M0 IC Malignant
J5
140 70 F Uterus Clear cell carcinoma * T1bN0M0 IB Malignant
J6
141 26 F Uterus Stromal sarcoma * T2N0M0G1 IB Malignant
J7
142 26 F Uterus Stromal sarcoma * T2N0M0G1 IB Malignant
J8
143 44 F Uterus Stromal sarcoma * T2N0M0G1 IB Malignant
J9
144 53 F Uterus Squamous cell carcinoma 3 T1cN0M0 IC Malignant
J10
145 55 F Uterus Squamous cell carcinoma 3 T1cN0M0 IC Malignant
J11
146 47 F Uterus Atypical hyperplasia 2--3 * * Hyperplasia
J12
147 48 F Uterus Atypical hyperplasia (smooth muscle and blood vessel) * * * Hyperplasia
J13
148 21 F Uterus Endometrium tissue * * * Normal
J14
149 21 F Uterus Endometrium tissue * * * Normal
J15
150 18 F Uterus Endometrium tissue * * * Normal
_pheochromocytoma_
Find overlapping cases with this tissue array:
  • FUR1501
    File Format: .xlsx
    Release Date: 2025-01-17 16:01:01
    Download
1.231175s